Rigel Pharma (RIGL) Reports In-Line Q4 EPS, Revenues Beat
Go back to Rigel Pharma (RIGL) Reports In-Line Q4 EPS, Revenues Beat| Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) | Delayed: 48.00 +0.91 (1.93%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $47.09 | 52 Week High | $4.38 | |||
| Open | $47.50 | 52 Week Low | $1.88 | |||
| Day High | $48.54 | P/E | N/A | |||
| Day Low | $47.23 | EPS | $-1.12 | |||
| Volume | 50,150 | |||||
